LXRX Financials
Lexicon Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$2.19
Market Cap
$327.22M
P/E Ratio
-3.5
EPS
$-0.19
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$31.08M
Gross Profit
-
Operating Income
-
Net Income
$-200.40M
EPS (Diluted)
$-0.63
Balance Sheet Highlights
Total Assets
$298.42M
Total Liabilities
$152.47M
Shareholders Equity
-
Cash & Equivalents
$66.66M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-178.78M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-85.9%
Net Margin
-96.8%
ROE
-45.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is LXRX revenue?
LXRX's most recent quarterly revenue was $31.08M. Annual revenue can be calculated by summing the four most recent quarters.
Is LXRX profitable?
LXRX reported a loss of $200.40M in the most recent quarter. The net profit margin is -96.8%.
What is LXRX market cap?
LXRX has a market capitalization of $327.22M, making it a small-cap stock.
Does LXRX have debt?
View LXRX's balance sheet for debt information.
What is LXRX cash flow?
Cash flow data is available in the full financial statements.